Commutability of two JCTLM-listed secondary reference materials for two commercial lithium assays

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 152-153

  Infusino, Ilenia ^a   Frusciante, Erika ^a   Ferrero, Carlo Alberto ^b   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Sentinel Diagnostics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM SALT; LITHIUM;

ACCURACY; BOOK; CALIBRATION; COLORIMETRY; COMMUTABILITY; DATA BASE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MONITORING; HUMAN; LETTER; MEDICAL SOCIETY; PHARMACEUTICAL CARE; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; REGRESSION ANALYSIS; STANDARDIZATION; THERAPEUTIC INDEX; UNCERTAINTY; VALIDATION STUDY; BLOOD; BLOOD ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

BLOOD CHEMICAL ANALYSIS; HUMANS; LITHIUM; REFERENCE STANDARDS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866511524     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.001     Document Type: Letter

References (5)

1. Amit, B.H., Weizman, A., Antidepressant treatment for acute bipolar depression: an update. Depress Res Treat, 2012, 10.1155/Depress Res Treat.2012.684725.
2. Yathan, L.N., Kennedy, S.H., Schaffer, A., Parick, S.V., Beaulieu, S., O'Donovan, C., et al. Canadian Network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11 (2009), 225–255.
3. McKnight, R.F., Adida, M., Budge, K., Stockton, S., Goodwin, G.M., Geddes, J.R., Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379 (2012), 721–728.
4. CLSI, Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline. CLSI document C53-A. 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
5. Fraser, C.G., Desirable standards of performance for therapeutic drug monitoring. Clin Chem 33 (1987), 387–389.